Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
8
×
life sciences
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
startups
8
×
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
abbvie
alzheimer's disease
eli lilly
pfizer
biogen
clinical trials
investing
johnson & johnson
medicare
What
drug
8
×
roundup
bio
companies
acquisitions
alzheimer’s
annual
attention
biggest
biotech
ceo
disease
earlier
nash
new
news
pipeline
price
prices
today
week
year
adds
ahead
albert
alliance
ambien
american
approval
approved
areas
asco
assessed
attendees
biogen’s
biopharmaceutical
biosciences
bio’s
bourla
brii
Language
unknown
unset
Current search:
startups
×
drug
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More